查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1178221

全球心血管器械市場分析2023-2033

Cardiovascular Devices Market Report 2023-2033
出版日期: | 出版商: Visiongain Reports Ltd. | 英文 273 Pages | 商品交期: 最快1-2個工作天內

價格

到 2023 年，全球心血管設備市場規模預計將超過 650 億美元，到 2033 年將以 6.92% 的複合年增長率增長。

日本、印度、中國、巴西等新興經濟體人口老齡化程度高，糖尿病發病率高，為心血管器械市場提供了重要的發展機遇。 根據世界衛生組織 (WHO) 的數據，每年有超過 1800 萬人死於心血管疾病 (CVD)。 這些死亡人數中超過四分之三死於心髒病發作和中風。 大約三分之二的 CVD 死亡發生在低收入和中等收入國家，其中高血壓是最重要的危險因素之一。 非傳染性疾病 (NCD) 約佔巴西所有死亡人數的四分之三。 因此，新興市場潛力預計將為該地區的市場參與者提供有利可圖的增長機會。

由於尖端技術被大量採用以應對日益增加的疾病負擔，預計未來心血管設備市場將呈指數級增長。 由於最先進設備的可用性，發達國家尤其越來越多地採用這些設備。 此外，在資助研發活動的同時，政府的舉措也變得更加積極。

本報告分析了全球心血管設備市場，概述了產品、基本市場結構和當前發展、主要驅動因素和製約因素、估計和預測市場規模（2023-2033 年）。2019年按疾病、類型分類的詳細趨勢、最終用戶、地區、主要國家、主要公司概況、COVID-19 的影響和恢復情景。

內容

第一章分析概述

第 2 章執行摘要

第 3 章市場概述

  • 主要發現
  • 市場動態
    • 市場驅動因素
    • 市場製約因素
    • 市場機會
  • 波特的五力分析
  • PESTLE 分析
  • COVID-19 影響分析

第 4 章心血管設備市場:按疾病分析

  • 主要分析結果
  • 市場吸引力指數:按疾病分類
  • 市場規模的估計和預測:按疾病分類
  • 高血壓
    • 按地區劃分的市場預測（十億美元，2023-2033 年）
    • 各地區的市場份額（2023/2033）
  • 房顫
  • 慢性缺血性心臟病
  • 中風
  • 心力衰竭
  • 其他疾病

第 5 章心血管設備市場:按類型分析

  • 主要分析結果
  • 市場吸引力指數:按類型細分
  • 市場規模的估計和預測:按類型
  • 診斷和監控設備
  • 治療和手術設備

第 6 章心血管設備市場:最終用戶分析

  • 主要分析結果
  • 市場吸引力指數:按最終用戶細分
  • 市場規模的估計和預測:按最終用戶
  • 醫院
  • 診斷實驗室
  • 家庭醫療護理和門診護理
  • 研究

第 7 章心血管設備市場:區域分析

  • 主要分析結果
  • 市場規模的估計和預測:按地區

第八章北美心血管器械市場分析

  • 主要分析結果
  • 北美心血管器械市場吸引力指數
  • 市場規模:按國家/地區（單位:十億美元，2023 年、2028 年、2033 年）
  • 市場規模估計和預測:按國家/地區分類（十億美元，2023-2033 年）
  • 市場規模估計和預測:按疾病分類（十億美元，2023-2033 年）
  • 按類型分類的市場規模估計和預測（單位:十億美元，2023-2033 年）
  • 市場規模估計和預測:按最終用戶分類（單位:十億美元，2023-2033 年）
  • 美國心血管器械市場分析
  • 加拿大心血管設備市場分析

第九章歐洲心血管器械市場分析

  • 德國心血管器械市場分析
  • 英國心血管器械市場分析
  • 法國心血管器械市場分析
  • 意大利心血管器械市場分析
  • 西班牙心血管器械市場分析
  • 俄羅斯心血管器械市場分析
  • 歐洲其他國家心血管器械市場分析

第 10 章亞太地區心血管設備市場分析

  • 日本心血管器械市場分析
  • 中國心血管器械市場分析
  • 印度心血管設備市場分析
  • 澳大利亞心血管器械市場分析
  • 韓國心血管器械市場分析
  • 亞太其他國家心血管器械市場分析

第 11 章拉丁美洲心血管設備市場分析

  • 巴西心血管器械市場分析
  • 墨西哥心血管器械市場分析
  • 拉丁美洲其他國家心血管器械市場分析

第 12 章中東和非洲心血管設備市場分析

  • 海灣合作委員會 (GCC) 國家心血管器械市場分析
  • 南非心血管器械市場分析
  • 其他中東和非洲國家的心血管器械市場分析

第13章公司簡介

  • Abbott
  • B. Braun SE
  • Boston Scientific Corporation
  • Becton, Dickinson and Company (BD)
  • Cardinal Health
  • Cook Group
  • Medtronic
  • Terumo Corporation
  • Koninklijke Philips N.V.
  • BIOTRONIK SE & CO. KG
  • W. L. Gore &Associates, Inc.
  • GE Healthcare
  • Canon Medical Systems Corporation
  • Johnson &Johnson Services, Inc.
  • Siemens Healthcare GmbH
  • Edwards Lifesciences Corporation
  • LivaNova PLC

第14章 結論與建議

Product Code: PHA1218

The global Cardiovascular Devices market is projected to grow at a CAGR of 6.92% by 2033.

“The Cardiovascular Devices Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growth Potential in Emerging Economies

The high occurrence of diabetes along with the large geriatric population in these emerging economies such as Japan, India, China, & Brazil provides substantial development opportunities for the cardiovascular devices market. As per the World Health Organization over 18 million people die due to CVDs each year. Of these deaths, over three-fourths deaths are attributed to heart attack and stroke. Besides, approximately two-thirds of CVD deaths take place in low-and middle-income nations where high blood pressure (BP) is amongst the most important risk factors. People at risk of CVD may exhibit high BP, glucose, and lipid along with overweight and obesity. To identify those at the maximum risk of CVDs along with to ensure they receive suitable treatment is expected to prevent premature deaths. In Brazil, non-communicable diseases (NCDs), accounted for approximately three-fourths of total deaths. Therefore, potential across emerging nations is projected to provide lucrative growth opportunities for the regional market players.

Growing Availability of Efficient Devices

The cardiovascular devices market is expected to witness exponential growth in the future with the high adoption of cutting-edge technologies to serve the rising disease burden. In addition, there has been an increase in the incidence of heart diseases globally, which leads to the demand for efficient and state-of-the-art heart devices. The availability of cutting-edge devices has led to the implementation of these devices in developed nations. Besides, there has been a rise in government initiatives along with funding for research and development activities. Further, investors are focusing on escalating the availability of advanced and economical cardiovascular devices in emerging markets. For instance, in 2020, AliveCor, one of the leading enterprise cardiac solution and AI-based ECG technology providers, launched KardiaMobile device in Mexico. This device is used to store, record, and transfer single-channel electrocardiogram rhythms from the patients. This launch was done through a partnership between AliveCor and Mexico-based Inpharamo, a medical solutions company. Hence, growth in accessibility of efficient devices is projected to offer lucrative growth prospects over the forecast period.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the cardiovascular devices market evolving?
  • What is driving and restraining the cardiovascular devices market?
  • How will each cardiovascular devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each cardiovascular devices submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading cardiovascular devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the cardiovascular devices projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of

cardiovascular devices projects taking place now and over the next 10 years?

  • Is there a greater need for product commercialisation to further scale the cardiovascular devices market?
  • Where is the cardiovascular devices market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the cardiovascular devices market today, and over the next 10 years:

  • Our 273-page report provides 112 tables and 170 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the cardiovascular devices market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Disease

  • Hypertension
  • Atrial Fibrillation
  • Chronic Ischemic Heart Diseases
  • Stroke
  • Heart Failure
  • Other Diseases

Type

  • Diagnostic and Monitoring Devices
  • Therapeutic and Surgical Devices

End-users

  • Hospitals
  • Diagnostic Laboratories
  • Home and Ambulatory Care
  • Research Laboratories

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Cardiovascular Devices Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

  • Abbott
  • B. Braun SE
  • BD
  • BIOTRONIK SE & CO. KG
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Cardinal Health
  • Cook Group
  • Edwards Lifesciences Corporation
  • GE Healthcare
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic plc
  • Siemens Healthcare GmbH
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

Overall world revenue for Cardiovascular Devices Market, 2023 to 2033 in terms of value the market will surpass US$65 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Cardiovascular Devices Market, 2023 to 2033 report help you?

In summary, our 270+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Cardiovascular Devices Market, 2023 to 2033 Market, with forecasts for Disease, Type, and End-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 21 key national markets - See forecasts for the Cardiovascular Devices Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 17 of the major companies involved in the Cardiovascular Devices Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Cardiovascular Devices Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Cardiovascular Devices Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Increasing Prevalence of Obesity
      • 3.2.1.2 Rising Consumption of Tobacco
      • 3.2.1.3 Increasing Incidence of Coronary Artery Diseases (CAD)
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Stringent Regulatory Requirements Delaying the Approval of Cardiac Devices
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Growth Potential in Emerging Economies
      • 3.2.3.2 Growing Availability of Efficient Devices
  • 3.3 Porter's Five Forces Analysis
    • 3.3.1 Supplier Power
    • 3.3.2 Buyer Power
    • 3.3.3 Competitive Rivalry
    • 3.3.4 Threat from Substitutes
    • 3.3.5 Threat of New Entrants
  • 3.4 PESTLE Analysis
  • 3.5 COVID-19 Impact Analysis

4 Cardiovascular Devices Market Analysis by Disease

  • 4.1 Key Findings
  • 4.2 Disease Segment: Market Attractiveness Index
  • 4.3 Cardiovascular Devices Market Size Estimation and Forecast by Disease
  • 4.4 Hypertension
    • 4.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Atrial Fibrillation
    • 4.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)
  • 4.6 Chronic Ischemic Heart Diseases
    • 4.6.1 Market Forecast by Region, 2023-2033 (US$ bn)
    • 4.6.2 Market Share by Region, 2023 & 2033 (%)
  • 4.7 Stroke
    • 4.7.1 Market Forecast by Region, 2023-2033 (US$ bn)
    • 4.7.2 Market Share by Region, 2023 & 2033 (%)
  • 4.8 Heart Failure
    • 4.8.1 Market Forecast by Region, 2023-2033 (US$ bn)
    • 4.8.2 Market Share by Region, 2023 & 2033 (%)
  • 4.9 Other Diseases
    • 4.9.1 Market Forecast by Region, 2023-2033 (US$ bn)
    • 4.9.2 Market Share by Region, 2023 & 2033 (%)

5 Cardiovascular Devices Market Analysis by Type

  • 5.1 Key Findings
  • 5.2 Type Segment: Market Attractiveness Index
  • 5.3 Cardiovascular Devices Market Size Estimation and Forecast by Type
  • 5.4 Diagnostic and Monitoring Devices
    • 5.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Therapeutic and Surgical Devices
    • 5.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)

6 Cardiovascular Devices Market Analysis by End-users

  • 6.1 Key Findings
  • 6.2 End-users Segment: Market Attractiveness Index
  • 6.3 Cardiovascular Devices Market Size Estimation and Forecast by End-users
  • 6.4 Hospitals
    • 6.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Diagnostic Laboratories
    • 6.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Home and Ambulatory Care
    • 6.6.1 Market Forecast by Region, 2023-2033 (US$ bn)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)
  • 6.7 Research Laboratories
    • 6.7.1 Market Forecast by Region, 2023-2033 (US$ bn)
    • 6.7.2 Market Share by Region, 2023 & 2033 (%)

7 Cardiovascular Devices Market Analysis by Region

  • 7.1 Key Findings
  • 7.2 Regional Market Size Estimation and Forecast

8 North America Cardiovascular Devices Market Analysis

  • 8.1 Key Findings
  • 8.2 North America Cardiovascular Devices Market Attractiveness Index
  • 8.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
  • 8.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
  • 8.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
  • 8.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
  • 8.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
  • 8.8 U.S. Cardiovascular Devices Market Analysis
  • 8.9 Canada Cardiovascular Devices Market Analysis

9 Europe Cardiovascular Devices Market Analysis

  • 9.1 Key Findings
  • 9.2 Europe Cardiovascular Devices Market Attractiveness Index
  • 9.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
  • 9.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
  • 9.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
  • 9.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
  • 9.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
  • 9.8 Germany Cardiovascular Devices Market Analysis
  • 9.9 UK Cardiovascular Devices Market Analysis
  • 9.10 France Cardiovascular Devices Market Analysis
  • 9.11 Italy Cardiovascular Devices Market Analysis
  • 9.12 Spain Cardiovascular Devices Market Analysis
  • 9.13 Russia Cardiovascular Devices Market Analysis
  • 9.14 Rest of Europe Cardiovascular Devices Market Analysis

10 Asia Pacific Cardiovascular Devices Market Analysis

  • 10.1 Key Findings
  • 10.2 Asia Pacific Cardiovascular Devices Market Attractiveness Index
  • 10.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
  • 10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
  • 10.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
  • 10.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
  • 10.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
  • 10.8 Japan Cardiovascular Devices Market Analysis
  • 10.9 China Cardiovascular Devices Market Analysis
  • 10.10 India Cardiovascular Devices Market Analysis
  • 10.11 Australia Cardiovascular Devices Market Analysis
  • 10.12 South Korea Cardiovascular Devices Market Analysis
  • 10.13 Rest of Asia Pacific Cardiovascular Devices Market Analysis

11 Latin America Cardiovascular Devices Market Analysis

  • 11.1 Key Findings
  • 11.2 Latin America Cardiovascular Devices Market Attractiveness Index
  • 11.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
  • 11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
  • 11.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
  • 11.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
  • 11.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
  • 11.8 Brazil Cardiovascular Devices Market Analysis
  • 11.9 Mexico Cardiovascular Devices Market Analysis
  • 11.10 Rest of Latin America Cardiovascular Devices Market Analysis

12 MEA Cardiovascular Devices Market Analysis

  • 12.1 Key Findings
  • 12.2 MEA Cardiovascular Devices Market Attractiveness Index
  • 12.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
  • 12.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
  • 12.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
  • 12.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
  • 12.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
  • 12.8 GCC Cardiovascular Devices Market Analysis
  • 12.9 South Africa Cardiovascular Devices Market Analysis
  • 12.10 Rest of MEA Cardiovascular Devices Market Analysis

13 Company Profiles

  • 13.1 Abbott
    • 13.1.1 Company Snapshot
    • 13.1.2 Company Overview
    • 13.1.3 Financial Analysis
      • 13.1.3.1 Net Revenue, 2017-2021
      • 13.1.3.2 Regional Market Shares, 2021
      • 13.1.3.3 Gross Profit, 2017-2021
      • 13.1.3.4 R&D, 2017-2021
    • 13.1.4 Product Benchmarking
    • 13.1.5 Strategic Outlook
  • 13.2 B. Braun SE
    • 13.2.1 Company Snapshot
    • 13.2.2 Company Overview
    • 13.2.3 Financial Analysis
      • 13.2.3.1 Net Revenue, 2017-2021
      • 13.2.3.2 Regional Market Shares, 2021
      • 13.2.3.3 Gross Profit, 2017-2021
      • 13.2.3.4 R&D, 2017-2021
    • 13.2.4 Product Benchmarking
    • 13.2.5 Strategic Outlook
  • 13.3 Boston Scientific Corporation
    • 13.3.1 Company Snapshot
    • 13.3.2 Company Overview
    • 13.3.3 Financial Analysis
      • 13.3.3.1 Net Revenue, 2017-2021
      • 13.3.3.2 Regional Market Shares, 2021
      • 13.3.3.3 Gross Profit, 2017-2021
      • 13.3.3.4 R&D, 2017-2021
    • 13.3.4 Product Benchmarking
    • 13.3.5 Strategic Outlook
  • 13.4 Becton, Dickinson and Company (BD)
    • 13.4.1 Company Snapshot
    • 13.4.2 Company Overview
    • 13.4.3 Financial Analysis
      • 13.4.3.1 Net Revenue, 2017-2021
      • 13.4.3.2 Regional Market Shares, 2021
      • 13.4.3.3 Gross Profit, 2017-2021
      • 13.4.3.4 R&D, 2017-2021
    • 13.4.4 Product Benchmarking
    • 13.4.5 Strategic Outlook
  • 13.5 Cardinal Health
    • 13.5.1 Company Snapshot
    • 13.5.2 Company Overview
    • 13.5.3 Financial Analysis
      • 13.5.3.1 Net Revenue, 2017-2021
      • 13.5.3.2 Regional Market Shares, 2021
    • 13.5.4 Product Benchmarking
    • 13.5.5 Strategic Outlook
  • 13.6 Cook Group
    • 13.6.1 Company Snapshot
    • 13.6.2 Company Overview
    • 13.6.3 Product Benchmarking
    • 13.6.4 Strategic Outlook
  • 13.7 Medtronic
    • 13.7.1 Company Snapshot
    • 13.7.2 Company Overview
    • 13.7.3 Financial Analysis
      • 13.7.3.1 Net Revenue, 2017-2021
      • 13.7.3.2 Regional Market Shares, 2021
      • 13.7.3.3 R&D, 2017-2021
    • 13.7.4 Product Benchmarking
    • 13.7.5 Strategic Outlook
  • 13.8 Terumo Corporation
    • 13.8.1 Company Snapshot
    • 13.8.2 Company Overview
    • 13.8.3 Financial Analysis
      • 13.8.3.1 Net Revenue, 2017-2021
      • 13.8.3.2 Regional Market Shares, 2022
      • 13.8.3.3 Gross Profit, 2017-2021
    • 13.8.4 Product Benchmarking
    • 13.8.5 Strategic Outlook
  • 13.9 Koninklijke Philips N.V.
    • 13.9.1 Company Snapshot
    • 13.9.2 Company Overview
    • 13.9.3 Financial Analysis
      • 13.9.3.1 Net Revenue, 2017-2021
      • 13.9.3.2 Regional Market Shares, 2021
      • 13.9.3.3 Gross Profit, 2017-2021
      • 13.9.3.4 R&D, 2017-2021
    • 13.9.4 Product Benchmarking
    • 13.9.5 Strategic Outlook
  • 13.10 BIOTRONIK SE & CO. KG
    • 13.10.1 Company Snapshot
    • 13.10.2 Company Overview
    • 13.10.3 Product Benchmarking
    • 13.10.4 Strategic Outlook
  • 13.11 W. L. Gore & Associates, Inc.
    • 13.11.1 Company Snapshot
    • 13.11.2 Company Overview
    • 13.11.3 Product Benchmarking
    • 13.11.4 Strategic Outlook
  • 13.12 GE Healthcare
    • 13.12.1 Company Snapshot
    • 13.12.2 Company Overview
    • 13.12.3 Financial Analysis
      • 13.12.3.1 Net Revenue, 2017-2021
      • 13.12.3.2 Regional Market Shares, 2021
      • 13.12.3.3 Gross Profit, 2017-2021
      • 13.12.3.4 R&D, 2018-2021
    • 13.12.4 Product Benchmarking
    • 13.12.5 Strategic Outlook
  • 13.13 Canon Medical Systems Corporation
    • 13.13.1 Company Snapshot
    • 13.13.2 Company Overview
    • 13.13.3 Financial Analysis
      • 13.13.3.1 Net Revenue, 2017-2021
      • 13.13.3.2 Regional Market Shares, 2021
      • 13.13.3.3 Gross Profit, 2017-2021
      • 13.13.3.4 R&D, 2017-2021
    • 13.13.4 Product Benchmarking
    • 13.13.5 Strategic Outlook
  • 13.14 Johnson & Johnson Services, Inc.
    • 13.14.1 Company Snapshot
    • 13.14.2 Company Overview
    • 13.14.3 Financial Analysis
      • 13.14.3.1 Net Revenue, 2017-2021
      • 13.14.3.2 Gross Profit, 2017-2021
      • 13.14.3.3 R&D, 2017-2021
    • 13.14.4 Product Benchmarking
    • 13.14.5 Strategic Outlook
  • 13.15 Siemens Healthcare GmbH
    • 13.15.1 Company Snapshot
    • 13.15.2 Company Overview
    • 13.15.3 Financial Analysis
      • 13.15.3.1 Net Revenue, 2017-2021
      • 13.15.3.2 Regional Market Shares, 2021
      • 13.15.3.3 R&D, 2017-2021
    • 13.15.4 Product Benchmarking
    • 13.15.5 Strategic Outlook
  • 13.16 Edwards Lifesciences Corporation
    • 13.16.1 Company Snapshot
    • 13.16.2 Company Overview
    • 13.16.3 Financial Analysis
      • 13.16.3.1 Net Revenue, 2017-2021
      • 13.16.3.2 Gross Profit, 2017-2021
      • 13.16.3.3 R&D, 2017-2021
    • 13.16.4 Product Benchmarking
    • 13.16.5 Strategic Outlook
  • 13.17 LivaNova PLC
    • 13.17.1 Company Snapshot
    • 13.17.2 Company Overview
    • 13.17.3 Financial Analysis
      • 13.17.3.1 Net Revenue, 2017-2021
      • 13.17.3.2 Gross Profit, 2017-2021
      • 13.17.3.3 R&D, 2017-2021
    • 13.17.4 Product Benchmarking
    • 13.17.5 Strategic Outlook

14 Conclusion and Recommendations

  • 14.1 Concluding Remarks from
  • 14.2 Recommendations for Market Players

List of Tables

  • Table 1 Cardiovascular Devices Market Snapshot, 2023 & 2033 (US$ billion, CAGR %)
  • Table 2 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 7 Hypertension Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 8 Atrial Fibrillation Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 9 Chronic Ischemic Heart Diseases Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 10 Stroke Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 11 Heart Failure Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 12 Other Diseases Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 13 Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 14 Diagnostic and Monitoring Devices Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 15 Therapeutic and Surgical Devices Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 16 Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 17 Hospitals Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 18 Diagnostic Laboratories Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 19 Home and Ambulatory Care Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 20 Research Laboratories Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 21 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 22 North America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 23 North America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 24 North America Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 25 U.S. Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 26 Canada Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 27 Europe Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 28 Europe Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 29 Europe Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 30 Europe Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 31 Germany Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 32 UK Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 33 France Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 34 Italy Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 35 Spain Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 36 Russia Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 37 Rest of Euorpe Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 38 Asia Pacific Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 39 Asia Pacific Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 40 Asia Pacific Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 41 Asia Pacific Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 42 Japan Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 43 China Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 44 India Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 45 Australia Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 46 South Korea Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 47 Rest of Asia Pacific Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 48 Latin America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 49 Latin America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 50 Latin America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 51 Latin America Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 52 Brazil Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 53 Mexico Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 54 Rest of Latin America Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 55 MEA Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 56 MEA Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 57 MEA Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 58 MEA Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 59 GCC Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 60 South Africa Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 61 Rest of MEA Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 62 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 63 Abbott: Product Benchmarking
  • Table 64 Abbott Laboratories: Strategic Outlook
  • Table 65 B. Braun SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 66 B. Braun SE: Product Benchmarking
  • Table 67 B. Braun SE: Strategic Outlook
  • Table 68 Boston Scientific Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 69 Boston Scientific Corporation: Product Benchmarking
  • Table 70 Boston Scientific Corporation: Strategic Outlook
  • Table 71 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 72 BD: Product Benchmarking
  • Table 73 BD: Strategic Outlook
  • Table 74 Cardinal Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 75 Cardinal Health: Product Benchmarking
  • Table 76 Cardinal Health, Inc.: Strategic Outlook
  • Table 77 Cook Group: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 78 Cook Group: Product Benchmarking
  • Table 79 Cook Group: Strategic Outlook
  • Table 80 Medtronic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 81 Medtronic: Product Benchmarking
  • Table 82 Medtronic: Strategic Outlook
  • Table 83 Terumo Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 84 Terumo Corporation: Product Benchmarking
  • Table 85 Terumo Corporation: Strategic Outlook
  • Table 86 Koninklijke Philips N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 87 Koninklijke Philips N.V.: Product Benchmarking
  • Table 88 Koninklijke Philips N.V.: Strategic Outlook
  • Table 89 Biotronik: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 90 Biotronik: Product Benchmarking
  • Table 91 Biotronik: Strategic Outlook
  • Table 92 W. L. Gore & Associates, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 93 W. L. Gore & Associates, Inc.: Product Benchmarking
  • Table 94 W. L. Gore & Associates, Inc.: Strategic Outlook
  • Table 95 GE Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 96 GE Healthcare: Product Benchmarking
  • Table 97 GE Healthcare: Strategic Outlook
  • Table 98 Canon Medical Systems Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 99 Canon Medical Systems Corporation: Product Benchmarking
  • Table 100 Canon Medical Systems Corporation: Strategic Outlook
  • Table 101 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 Johnson & Johnson Services, Inc.: Product Benchmarking
  • Table 103 Johnson & Johnson Services, Inc.: Strategic Outlook
  • Table 104 Siemens Healthcare GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 105 Siemens: Product Benchmarking
  • Table 106 Siemens: Strategic Outlook
  • Table 107 Edwards Lifesciences Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 108 Edwards Lifesciences Corporation: Product Benchmarking
  • Table 109 Edwards Lifesciences Corporation: Strategic Outlook
  • Table 110 LivaNova PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 111 LivaNova PLC: Product Benchmarking
  • Table 112 LivaNova PLC: Strategic Outlook
  •  

List of Figures

  • Figure 1 Cardiovascular Devices Market Segmentation
  • Figure 2 Cardiovascular Devices Market by Disease: Market Attractiveness Index
  • Figure 3 Cardiovascular Devices Market by Type: Market Attractiveness Index
  • Figure 4 Cardiovascular Devices Market by End-users: Market Attractiveness Index
  • Figure 5 Cardiovascular Devices Market Attractiveness Index by Region
  • Figure 6 Cardiovascular Devices Market: Market Dynamics
  • Figure 7 Number of Overweight & Obese People Globally (Billion)
  • Figure 8 Number of Diabetic People Globally (Million)
  • Figure 9 Diabetes Around the World, 2021
  • Figure 10 Cardiovascular Devices Market: PESTLE Analysis
  • Figure 11 COVID Impact Analysis: Cardiovascular Devices Market Recovery Scenarios
  • Figure 12 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): "V" Shaped Recovery
  • Figure 13 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): "U" Shaped Recovery
  • Figure 14 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): "W" Shaped Recovery
  • Figure 15 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): "L" Shaped Recovery
  • Figure 16 Cardiovascular Devices Market Attractiveness Index by Disease
  • Figure 17 Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
  • Figure 18 Cardiovascular Devices Market Share Forecast by Disease, 2023, 2028, 2033 (%)
  • Figure 19 Hypertension Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 20 Hypertension Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 21 Atrial Fibrillation Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 22 Atrial Fibrillation Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 23 Chronic Ischemic Heart Diseases Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 24 Chronic Ischemic Heart Diseases Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 25 Stroke Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 26 Stroke Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 27 Heart Failure Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 28 Heart Failure Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 29 Other Diseases Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 30 Other Diseases Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 31 Cardiovascular Devices Market Attractiveness Index by Disease
  • Figure 32 Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
  • Figure 33 Cardiovascular Devices Market Share Forecast by Type, 2023, 2028, 2033 (%)
  • Figure 34 Diagnostic and Monitoring Devices Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 35 Diagnostic and Monitoring Devices Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 36 Therapeutic and Surgical Devices Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 37 Therapeutic and Surgical Devices Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 38 Cardiovascular Devices Market Attractiveness Index by End-users
  • Figure 39 Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
  • Figure 40 Cardiovascular Devices Market Share Forecast by End-users, 2023, 2028, 2033 (%)
  • Figure 41 Hospitals Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 42 Hospitals Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 43 Diagnostic Laboratories Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 44 Diagnostic Laboratories Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 45 Home and Ambulatory Care Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 46 Home and Ambulatory Care Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 47 Research Laboratories Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 48 Research Laboratories Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 49 Cardiovascular Devices Market Forecast by Region 2023 & 2033 (Revenue, CAGR%)
  • Figure 50 Cardiovascular Devices Market Share Forecast by Region 2023, 2028, 2033 (%)
  • Figure 51 Cardiovascular Devices Market by Region, 2023-2033 (US$ bn)
  • Figure 52 North America Cardiovascular Devices Market Attractiveness Index
  • Figure 53 North America Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
  • Figure 54 North America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
  • Figure 55 North America Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 56 North America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
  • Figure 57 North America Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
  • Figure 58 North America Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
  • Figure 59 North America Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 60 North America Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
  • Figure 61 North America Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 62 U.S. Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 63 Canada Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 64 Europe Cardiovascular Devices Market Attractiveness Index
  • Figure 65 Europe Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
  • Figure 66 Europe Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
  • Figure 67 Europe Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 68 Europe Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
  • Figure 69 Europe Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
  • Figure 70 Europe Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
  • Figure 71 Europe Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 72 Europe Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
  • Figure 73 Europe Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 74 Germany Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 75 UK Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 76 France Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 77 Italy Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 78 Spain Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 79 Russia Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 80 Rest of Europe Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 81 Asia Pacific Cardiovascular Devices Market Attractiveness Index
  • Figure 82 Asia Pacific Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
  • Figure 83 Asia Pacific Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
  • Figure 84 Asia Pacific Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 85 Asia Pacific Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
  • Figure 86 Asia Pacific Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
  • Figure 87 Asia Pacific Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
  • Figure 88 Asia Pacific Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 89 Asia Pacific Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
  • Figure 90 Asia Pacific Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 91 Japan Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 92 China Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 93 India Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 94 Australia Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 95 South Korea Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 96 Rest of Asia Pacific Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 97 Latin America Cardiovascular Devices Market Attractiveness Index
  • Figure 98 Latin America Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
  • Figure 99 Latin America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
  • Figure 100 Latin America Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 101 Latin America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
  • Figure 102 Latin America Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
  • Figure 103 Latin America Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
  • Figure 104 Latin America Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 105 Latin America Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
  • Figure 106 Latin America Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 107 Brazil Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 108 Mexico Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 109 Rest of Latin America Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 110 MEA Cardiovascular Devices Market Attractiveness Index
  • Figure 111 MEA Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
  • Figure 112 MEA Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
  • Figure 113 MEA Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 114 MEA Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
  • Figure 115 MEA Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
  • Figure 116 MEA Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
  • Figure 117 MEA Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 118 MEA Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
  • Figure 119 MEA Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 120 GCC Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 121 South Africa Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 122 Rest of MEA Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 123 Abbott: Net Revenue, 2017-2021 (US$ million, AGR %)
  • Figure 124 Abbott: Regional Market Shares, 2021
  • Figure 125 Abbott: Gross Profit, 2017-2021 (US$ million, AGR%)
  • Figure 126 Abbott: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 127 B. Braun SE: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 128 B. Braun SE: Regional Market Shares, 2021
  • Figure 129 B. Braun SE: Gross Profit, 2017-2021 (US$ million, AGR%)
  • Figure 130 B. Braun SE: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 131 Boston Scientific Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 132 Boston Scientific Corporation: Regional Market Shares, 2021
  • Figure 133 Boston Scientific Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
  • Figure 134 Boston Scientific Corporation: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 135 BD: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 136 BD: Regional Market Shares, 2021
  • Figure 137 BD: Gross Profit, 2017-2021 (US$ million, AGR%)
  • Figure 138 BD: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 139 Cardinal Health: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 140 Cardinal Health: Regional Market Shares, 2021
  • Figure 141 Medtronic: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 142 Medtronic: Regional Market Shares, 2021
  • Figure 143 Medtronic: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 144 Terumo Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 145 Terumo Corporation: Regional Market Shares, 2022
  • Figure 146 Terumo Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
  • Figure 147 Koninklijke Philips N.V.: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 148 Koninklijke Philips N.V.: Regional Market Shares, 2021
  • Figure 149 Koninklijke Philips N.V.: Gross Profit, 2017-2021 (US$ million, AGR%)
  • Figure 150 Koninklijke Philips N.V.: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 151 GE Healthcare: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 152 GE Healthcare: Regional Market Shares, 2021
  • Figure 153 GE Healthcare: Gross Profit, 2017-2021 (US$ million, AGR%)
  • Figure 154 GE Healthcare: R&D, 2018-2021 (US$ million, AGR%)
  • Figure 155 Canon Medical Systems Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 156 Canon Medical Systems Corporation: Regional Market Shares, 2021
  • Figure 157 Canon Medical Systems Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
  • Figure 158 Canon Medical Systems Corporation: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 159 Johnson & Johnson Services, Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 160 Johnson & Johnson Services, Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
  • Figure 161 Johnson & Johnson Services, Inc.: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 162 Siemens: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 163 Siemens: Regional Market Shares, 2021
  • Figure 164 Siemens: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 165 Edwards Lifesciences Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 166 Edwards Lifesciences Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
  • Figure 167 Edwards Lifesciences Corporation: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 168 LivaNova PLC: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 169 LivaNova PLC: Gross Profit, 2017-2021 (US$ million, AGR%)
  • Figure 170 LivaNova PLC: R&D, 2017-2021 (US$ million, AGR%)